# Telomir Pharmaceuticals, Inc.: Form 8-K, filed Feb 5, 2026

- Company: [Telomir Pharmaceuticals, Inc.](/companies/telo.md) (CIK 1971532)
- Form: 8-K
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 07:30 ET
- Period: 2026-02-05
- Accession: 0001493152-26-005199
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971532/000149315226005199/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971532/000149315226005199/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971532/000149315226005199/form8-k.htm

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-005199. Last ingested by Listed: Nov 6, 2026, 17:47 ET. No prices; not investment advice.